Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
Corin Cesaric-Epple is a Flex Editor at CNET. She received her bachelor's degree in journalism from the University of Missouri-Columbia. Before joining CNET, she covered crime at People Magazine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results